Please login to the form below

Not currently logged in
Email:
Password:

New executive at PhRMA

Pharmaceutical Research and Manufacturers of America, the industry's main US trade group, has confirmed former IBM executive Rod Hunter as the organisation's new senior vice president of international advocacy

Pharmaceutical Research and Manufacturers of America (PhRMA), the industry's main US trade group, has confirmed former IBM executive Rod Hunter as the organisation's new senior vice president of international advocacy, effective June 10.

Hunter will be responsible for leading and overseeing PhRMA's international advocacy functions, reporting to executive vice president of advocacy Chip Davis.

At IBM, Hunter served as vice president, governmental programmes, Europe. Earlier in his career, he served as special assistant to the president and senior director of the White House's National Security Council under President George W Bush, coordinating the administration's international economic agenda, including trade, intellectual property, investment, energy and environmental policies.

"With his broad international trade experience in both the private and public sectors, Rod brings to bear a keen understanding of the complex policies and market dynamics inherent to an increasingly global economy," Davis said in a statement.

13th May 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Onyx Health Ltd

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics